Zaki EA, Freilinger T, Klopstock T, Baldwin EE, Heisner KR, Adams K, et al
Patients with lower-sensitivity genetic profiles often experience milder nausea and faster tolerance, while those with higher-sensitivity profiles may benefit from microdose protocols or slower dose escalation
However, ovarian cancer cells with low intracellular iron pools are resistant to erastin treatment [95] , indicating that iron levels can determine cell sensitivity to ferroptosis
L-cells sit along the distal small intestine and colon
Common experiences include nausea (especially when starting or escalating doses), occasional vomiting, constipation, and reduced appetite for favorite foodsironically, the appetite reduction is often the desired therapeutic effect